Skip to main content

/ Diigo Community/ Group items tagged #non_small_cell_lung_cancer.

Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

ESMO 2019: Merck unveils neoadjuvant/adjuvant TNBC trial results - 1 views

www.clinicaltrialsarena.com/...nt-adjuvant-tnbc-trial-results

#esmo_2019 #Samsung_Bioepis_reveals #esmo_2019_dates #Bevacizumab #biosimilar_trial_result #non_small_cell_lung_cancer.

shared by jacob logan on 04 Oct 19 - No Cached

jacob logan on 04 Oct 19

A regimen of neoadjuvant Keytruda and chemotherapy extended pathological complete response (pCR) rates by 13.6% compared to chemotherapy alone in patients with early triple-negative breast cancer (TNBC), according to findings from the Phase III Keynote-522 study presented at the ESMO Congress 2019.

<div class="cArrow"> </div><div class="cContentInner"> A regimen of neoadjuvant Keytruda and chemotherapy extended pathological complete response (pCR) rates by 13.6% compared to chemotherapy alone in patients with early triple-negative breast cancer (TNBC), according to findings from the Phase III Keynote-522 study presented at the ESMO Congress 2019.</div>

...

Cancel

ESMO 2019: Samsung Bioepis reveals Bevacizumab biosimilar trial result - 1 views

www.clinicaltrialsarena.com/...samsung-bevacizumab-biosimilar

#esmo_2019 #Samsung_Bioepis_reveals # esmo_2019_dates #Bevacizumab #biosimilar_trial_result #non_small_cell_lung_cancer.

shared by jacob logan on 03 Oct 19 - No Cached

jacob logan on 03 Oct 19

A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).

<div class="cArrow"> </div><div class="cContentInner">A Phase 3 study comparing Samsung Bioepis' SB8 with Avastin in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC) demonstrated equivalent efficacy in terms of risk ratio of overall response rate (ORR).</div>

...

Cancel

Blood test may replace biopsy in advanced lung cancer - 1 views

www.medicaldevice-network.com/...lung-cancer-blood-test

#Blood_Test #Replace_Biopsy #Lung_Cancer #NSCLC #Non_Small_Cell_Lung_Cancer #Small_Lung_Cancer #Tumor #Tumor_Treatment

shared by jacob logan on 22 Oct 19 - No Cached

jacob logan on 22 Oct 19

Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.

<div class="cArrow"> </div><div class="cContentInner">Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.</div>

...

Cancel

ESMO 2019: Early colon cancer detection blood test has positive result - 1 views

www.medicaldevice-network.com/...so-2019-novigenix-colon-cancer

#ESMO_2019 #Blood_Test #Replace_Biopsy #Lung_Cancer #NSCLC #Non_Small_Cell_Lung_Cancer #Small_Lung_Cancer #Tumor #Tumor_Treatment

shared by jacob logan on 29 Oct 19 - No Cached

jacob logan on 29 Oct 19

Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.

<div class="cArrow"> </div><div class="cContentInner"> Immuno-Transcriptomics firm Novigenix has received positive results from its early colon cancer detection blood test at the European Society for Medical Oncology (ESMO) 2019.</div>

...

Cancel

1 - 4 of 4

Showing 20▼ items per page

Related searches